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Longitudinal gut virome analysis identifies
specific viral signatures that precede necrotizing
enterocolitis onset in preterm infants
Emily A. Kaelin1,2, Cynthia Rodriguez3, Carla Hall-Moore3, Julie A. Hoffmann3, Laura A. Linneman3,
I. Malick Ndao3, Barbara B. Warner3, Phillip I. Tarr 3,4, Lori R. Holtz 3 ✉ and Efrem S. Lim 1,2 ✉
Necrotizing enterocolitis (NEC) is a serious consequence of preterm birth and is often associated with gut bacterial microbiome
alterations. However, little is known about the development of the gut virome in preterm infants, or its role in NEC. Here, using
metagenomic sequencing, we characterized the DNA gut virome of 9 preterm infants who developed NEC and 14 gestational
age-matched preterm infants who did not. Infants were sampled longitudinally before NEC onset over the first 11 weeks of life.
We observed substantial interindividual variation in the gut virome between unrelated preterm infants, while intraindividual
variation over time was significantly less. We identified viral and bacterial signatures in the gut that preceded NEC onset.
Specifically, we observed a convergence towards reduced viral beta diversity over the 10 d before NEC onset, which was driven
by specific viral signatures and accompanied by specific viral-bacterial interactions. Our results indicate that bacterial and viral
perturbations precede the sudden onset of NEC. These findings suggest that early life virome signatures in preterm infants may
be implicated in NEC.

N

ecrotizing enterocolitis (NEC) is a serious and sudden
necroinflammatory complication of preterm birth1. NEC
incidence in infants born at <32 weeks’ gestation ranges
from 2 to 7% in high-income countries, with case mortality ranging from 22 to 38%2. NEC survivors face lifelong sequelae, including short bowel syndrome and neurodevelopmental disabilities1.
The aetiology of NEC is unclear but risk factors in addition to
preterm birth include formula feeding and prolonged use of antibiotics early in life3. Numerous studies suggest that gut microbiome
alterations contribute to the development of NEC4–6, with several
recent large studies converging on a risk community state consisting of over-representation of Gram-negative facultative bacteria
(for example, Gammaproteobacteria, Proteobacteria) and relative
under-representation of obligate anaerobic bacteria4,6. Notably,
however, no single bacterial genus, species, serotype or sequence
type has reproducibly been implicated as the cause of NEC. How
the microbiome contributes to NEC pathogenesis is unclear but
proposed mechanisms include stimulation of Toll-like receptor 4 by
lipopolysaccharide from Gram-negative bacteria, leading to poorly
controlled inflammatory responses in the preterm gut1,7,8. Some
reports have associated eukaryotic viruses with NEC9–13 and a recent
next-generation sequencing (NGS) study described a limited spectrum of bacteriophages, including enrichment of Staphylococcus
phage 363_30, before NEC in preterm infants5, but these studies did
not address overall virome composition and dynamics.
Factors such as breastfeeding, delivery route, antibiotics and
the environment influence gut bacterial community composition
and microbiome maturation14,15. Time series studies of the preterm
gut microbiome identified choreographed patterns of microbiome
acquisition16,17. For example, stool samples from preterm infants in
the first days of life are characterized by high proportions of Bacilli,
giving way over time to Gammaproteobacteria and then Clostridia16.

In contrast to the relatively stable adult virome18,19, a small number of studies have been performed, which suggest that temporal
changes are common in the gut viromes of infants and young children, including changes in bacteriophage diversity and increases
in prevalence and richness of eukaryotic viruses over time20–22.
Bacteriophages are believed to influence gut bacterial communities23,24. Recent experimental evidence demonstrated that bacteriophages influence microbiome composition in mice25 and affect the
microbiome and intestinal health after fecal microbiota transfer26,27.
Moreover, virome alterations have been associated with inflammatory bowel disease and colitis, suggesting that the virome plays a
role in digestive disorders28–30. Given the importance of microbiome acquisition and of the interacting role played by the virome
in health and disease, it is logical to study the development of the
preterm virome over time to understand factors that may influence
health and disease.
In this study, we present a longitudinal, metagenomic NGS study
of the gut viromes of 23 preterm infants. This cohort includes 9
infants who subsequently developed NEC and 14 controls matched
for gestational age at birth and birthweight. We found substantial interpersonal variation in gut viromes across both phage
and eukaryotic viruses at various ages in infants at risk for NEC.
However, the viromes of infants who developed NEC converged
towards a reduced level of beta diversity before NEC ensued and
this convergence was characterized by specific viral signatures.

Results

Preterm virome varies within and between infants over time.
We analysed 138 stool samples collected over time from 23 preterm infants in the neonatal intensive care unit (NICU) at St. Louis
Children’s Hospital (Supplementary Tables 1 and 2). Nine of the
infants (cases) developed NEC and 14 infants matched for weight
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Table 1 | Cohort characteristics
Variable

Controls n = 14

Cases n = 9

Statistical significance

Gestational age at birth, weeks

25.5 (24.9–26.0)

25.0 (23.1–25.4)

NS, P = 0.19

Birth weight, g

810 (670–920)

780 (570–955)

NS, P = 0.82

Vaginal delivery

2 (14%)

4 (44%)

NS, P = 0.16

Male

5 (36%)

6 (67%)

NS, P = 0.21

1 and 5 min Apgar scores

2 (1–6) and 5.5 (2.8–6.3)

3 (1.5–5) and 5 (4.5–6)

NS, P = 0.93/NS, P = 0.96

Exposed to human milk during sampling period (yes)

13 (93%)

8 (89%)

NS, P > 0.99

Percentage of days of antibiotic exposure during the sampling period

25.3% (6.1–33.3%)

10.5% (0–29.4%)

NS, P = 0.25

Stool samples analysed per infant

7 (6–8)

4 (4–6)

P = 0.01

Statistical significance assessed by two-sided Mann–Whitney U-test for continuous variables and two-sided Fisher’s exact test for categorical variables. NS, not significant. Data are expressed as the
median (IQR) or number (percentage) as appropriate.

and gestational age at birth (controls) did not. Cases resembled controls in terms of sex and delivery route (Table 1). Postmenstrual age
(PMA) (defined as weeks of gestation at birth plus postnatal age)
at sample collection ranged between 24.9 and 34.2 weeks for case
infants and 25.0 and 36.1 weeks for control infants (Extended Data
Fig. 1a). Day of life at sample collection ranged from 6.5 to 75.1 for
control infants and 2.4 to 58.2 for case infants. Two samples with
sparse reads (6 and 29) were excluded from the analysis. We analysed
a median of 412,905 (interquartile range (IQR) = 288,727–521,394)
quality-filtered reads per sample (Supplementary Table 3). A total
of 778,612 contigs were assembled from the infant stool samples
(Supplementary Table 4), of which 40,210 were identified as viral.
A large proportion of the virome of control preterm infants
could not be assigned family-level taxonomy (unclassified viruses)
(median relative abundance = 85.3%; IQR = 79.8–91.3%) (Fig. 1a
and Supplementary Table 5). Viral contigs that could be classified belonged to bacteriophage families including Myoviridae,
Podoviridae and Siphoviridae. These families were present in controls at median relative abundances of 5.1% (IQR = 1.7–8.4%),
1.8% (IQR = 0.6–2.6%) and 3.8% (IQR = 1.9–5.0%), respectively.
Microviridae was highly abundant (19.2%) in a single sample but
much less abundant (median = 0.1%; IQR = 0–0.2%) in the remaining 94 control samples. Low-abundant phage families in the stools
of control infants included Gokushovirinae, Herelleviridae and
Tectiviridae. Some control samples had high relative abundance
of eukaryotic virus families Anelloviridae (1 sample, 20.7%) and
Circoviridae (2 samples, 10.4 and 15.0%), while other control samples
had considerably lower relative abundances (Anelloviridae, 8 samples, IQR = 0.1–0.9%; Circoviridae, 31 samples, IQR = 0.01–0.3%).
Relative abundances of bacteriophage and eukaryotic virus families
varied between control infants in each week of the study, spanning
the 26th to the 37th week PMA. Family relative abundance also varied within individuals over time. Grouping samples by week of life,
rather than the PMA at which they were obtained, yielded similar
variation at each time point (Extended Data Fig. 2a). Contig richness and Shannon diversity varied within and between individuals
(Fig. 1b and Supplementary Table 2). After controlling for repeated
sampling of individuals by linear mixed modelling, neither richness
nor Shannon diversity changed significantly over time (P = 0.47 and
P = 0.61, respectively). Finally, we compared viromes between control preterm infants by examining beta diversity. Median weighted
Bray–Curtis dissimilarity, which accounts both for virus presence–
absence and virus abundance, was significantly lower within than
between infants (Mann–Whitney U-test, P < 0.0001) (Fig. 1c and
Supplementary Table 6). We observed similar results for Sorensen
dissimilarity (P < 0.0001) and Hellinger distance (P < 0.0001)
(Extended Data Fig. 2b and Supplementary Tables 7 and 8). Principal
coordinates analysis (PCoA) on weighted Bray–Curtis dissimilarity showed substantial overlap of samples obtained at different
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postmenstrual ages, while permutational multivariate analysis of
variance (PERMANOVA) testing showed a significant association
with PMA (P = 0.05) (Fig. 1d and Supplementary Table 9). Taken
together, these results demonstrate high inter- and intraindividual
variation in the preterm infant gut virome. However, gut viromes in
individual infants were more similar to self than to non-self (other
infants) over time, indicating some degree of intra-host stability.
Preterm NEC case infant viromes vary when compared by age.
We next examined the viromes of the nine case infants who subsequently developed NEC. Median age at NEC onset was 31.1 weeks’
PMA (IQR = 30.0–32.8 weeks); 4 case infants died. As with the control preterm infants, a substantial proportion of case infant viromes
consisted of viruses that could not be assigned family-level taxonomy and were categorized as unclassified viruses (median relative
abundance = 84.5%; IQR = 75.8–88.2%). Classifiable viral contigs in
the case viromes included the bacteriophage families Myoviridae,
Podoviridae and Siphoviridae, with median relative abundances
of 5.6% (IQR = 1.6–7.4%), 2.7% (1.8–4.1%) and 2.9% (1.7–5.4%),
respectively (Fig. 2a and Supplementary Table 5). As in the controls, Microviridae were present at high relative abundance (55.4%)
in only 1 sample and at lower relative abundances in other samples (median relative abundance = 0.1%; IQR = 0.01–0.2%). Other
low relative abundance bacteriophages include Gokushovirinae,
Herelleviridae, and Tectiviridae. Several samples contained eukaryotic viruses belonging to the Anelloviridae (9 samples, median
relative abundance = 0.9%; IQR = 0.2–1.3%) and Circoviridae (13
samples, median relative abundance = 0.02%; IQR = 0.01–0.04%)
families. We found high variability in virus family proportions at
each time point and also within individuals over time. As in the controls, we saw similar variability after grouping samples by week of
life (Extended Data Fig. 2c). Shannon diversity and richness varied
between individuals and over time (Fig. 2b) but did not change significantly by PMA (linear mixed modelling, P = 0.91 and P = 0.88,
respectively). As with control infants, median weighted Bray–Curtis
dissimilarity within individual case infants was significantly less than
between individuals (Mann–Whitney U-test, P < 0.0001) (Fig. 2c
and Supplementary Table 6). Results were similar for Sorensen dissimilarity (P = 0.04) and Hellinger distance (P = 0.002) (Extended
Data Fig. 2d and Supplementary Tables 7 and 8). PCoA analysis on
weighted Bray–Curtis dissimilarity did not show clustering based
on PMA (PERMANOVA, P = 0.57) (Fig. 2d and Supplementary
Table 9). We next compared virome composition between case and
control infants by PCoA (Fig. 2e and Supplementary Table 9). Case
and control samples overlapped substantially, while PERMANOVA
testing showed no significant difference between the two groups
(P > 0.99). These results suggest that like the gut viromes of preterm
infants without NEC, the gut viromes of infants who subsequently
developed NEC vary between and within individuals over time.
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Fig. 1 | Gut virome in preterm infants who did not develop NEC (controls). a, Virus family relative abundance in samples from control infants, grouped by
PMA. Multiple pie charts within a square indicate multiple samples from the same infant in one week. b, Viral contig richness and alpha diversity (Shannon
index) in control samples over time. Trend lines and 95% confidence bands were generated using LOESS smoothing in R. Smoothing level: span = 0.5.
c, Median weighted Bray–Curtis dissimilarity within individual control infants and between individual control infants, n = 14 infants. Box limits, 25th and
75th percentiles; whiskers, 2.5 and 97.5 percentiles. Statistical significance was assessed by two-sided Mann–Whitney U-test, P < 0.0001. d, PCoA of
control samples, using weighted Bray–Curtis distance. Statistical significance of PMA (continuous variable) was assessed by PERMANOVA. Samples were
colour-coded by PMA.

Virome convergence precedes NEC onset. We next considered the
possibility that virome community dynamics might influence NEC
development by examining virome progression in cases relative to
the time of NEC onset. We used a sliding 7 d window with steps of 2 d
between windows, counting backwards from the day NEC occurred.
Sorensen dissimilarity between case infants, which considers virus
presence–absence, decreased in sliding windows spanning the 10 d
immediately before NEC onset (Fig. 3a, red and Supplementary
Table 10). Specifically, viral populations more closely resembled each
other in this interval. In contrast, dissimilarity between matched
samples among controls was stable during this immediate pre-NEC
interval (Fig. 3a, blue and Supplementary Table 10). Between-case
dissimilarity was less than between-control dissimilarity at windows
spanning 11–4 d, 9–2 d and 7–0 d before NEC (Mann–Whitney
U-test; P = 0.002, P = 0.003 and P = 0.05, respectively). This suggests

that the beta diversity of the gut viromes of case infants begins to
converge about 10 d before NEC onset. We then used linear discriminant analysis (LDA) effect size (LEfSe) analysis to identify the
viral contigs associated with the 10 d period immediately before
NEC onset compared to the immediate antecedent period (that is,
11–46 d before NEC onset). We identified 137 contigs associated
with the time period 0–10 d before NEC (NEC-associated contigs),
whereas only 11 contigs were associated with the earlier period, that
is, 11–46 d before NEC onset (Fig. 3b). Most of these contigs could
not be assigned family-level taxonomy, although some belonged to
Myoviridae, Podoviridae and Siphoviridae (Supplementary Table 11).
We next validated the discriminant analyses by comparing the
prevalence and abundance (reads per kilobase (RPK)) of the
NEC-associated contigs. We identified NEC-associated contigs in
case samples 10–25 d before NEC; however, prevalence and average
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Fig. 2 | Gut virome over time in infants who developed NEC (cases). a, Virus family relative abundance in case samples, grouped by PMA. Multiple pie
charts within a square indicate multiple samples from the same infant in one week. b, Viral contig richness and Shannon diversity in case samples over time.
Trend lines and 95% confidence bands were generated using LOESS smoothing in R, with a span of 0.5. c, Median weighted Bray–Curtis dissimilarity within
individual case infants and between individual case infants, n = 9 infants. Box limits, 25th and 75th percentiles; whiskers, 2.5 and 97.5 percentiles. Statistical
significance was assessed by two-sided Mann–Whitney U-test, P < 0.0001. d, PCoA of case samples using weighted Bray–Curtis distance. Statistical
significance of PMA (continuous variable) assessed by PERMANOVA. Samples were colour-coded by PMA. e, PCoA comparing case and control samples
using weighted Bray–Curtis distance. Statistical significance was assessed by PERMANOVA.

abundance increased significantly in the 10 d before this event (Fig.
3c and Supplementary Table 12; Friedman test with Dunn’s multiple
comparisons, see Supplementary Table 13 for the P values). The
overall relative abundance of the NEC-associated contigs was low
(<20%, data not shown), suggesting that changes in low-abundant
viruses are implicated in NEC virome risk convergence. This is con656

sistent with the Sorensen dissimilarity data, which do not consider
species abundance. We reasoned that a NEC-associated signature
should be progressively enriched closer to NEC onset. Moreover,
enrichment should be specific to case infants but not gestational
age-matched control infants. Indeed, prevalence and abundance
of NEC-associated contigs increased in case infants in relation to
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controls (Fig. 3d (compare red to blue) and Supplementary Table
12). By contrast, prevalence and abundance of NEC-associated contigs decreased in controls in proximity to case NEC onset (Extended
Data Fig. 3a and Supplementary Table 14). To determine if the
large number of contigs associated with NEC onset was characteristic of longitudinal virome development, we conducted a similar
LEfSe analysis using control samples. Specific contigs were associated with late and early time points in control infants (< or >10 d
before their respective case infant’s time of NEC onset (Extended
Data Fig. 3b and Supplementary Table 15). Prevalence and abundance of the control late-associated contigs increased significantly
over time in controls, whereas in case infants prevalence of these
contigs varied and abundance rose slightly (Extended Data Fig. 3c,d
and Supplementary Tables 16–18). Notably, the NEC-associated
contigs in case infants were different from the late-associated contigs in controls. Of the NEC-associated contigs with at least 5 open
reading frames (ORFs), 31.7% were predicted to have temperate lifestyles and 68.3% were predicted to be lytic (Extended Data
Fig. 3e). The proportions of predicted lytic and temperate viruses
did not differ significantly between NEC-associated contigs, control
late-associated contigs and the dataset as a whole (chi-squared test,
P > 0.9). Taken together, these results indicate that the gut viromes
of preterm infants who developed NEC converged in beta diversity
before the event and this convergence was driven by enrichment of
specific viruses and loss of others. While control infants also gained
and lost viral contigs over time, the specific viruses gained and lost
differed from those gained and lost in case infants. Furthermore,
this turnover was insufficient to drive a substantial change in beta
diversity in control infants.
Bacterial-viral interactions before NEC onset. We next considered
the possibility that virome convergence might mirror changes in the
bacterial microbiome before NEC onset. Therefore, we used a similar approach to examine bacterial sequencing data6 from these samples (that is, in reference to when NEC occurred). Major classes of
bacteria found in cases and controls included Gammaproteobacteria,
Clostridia and Bacilli (Fig. 4a and Supplementary Table 19).
Enterococcaceae abundance was significantly different between case
and control infants (Extended Data Fig. 4a; ANCOM-II, adjusted
for repeat sampling). Differences in Gammaproteobacteria, Bacilli,
Enterobacteriaceae and Veillonellaceae abundances were not significant when adjusted for repeated sampling (Extended Data Fig. 4a,b).
Interestingly, unlike virome beta diversity, bacterial beta diversity in
case infants was stable in windows spanning the 25 d before NEC
(Fig. 4b and Supplementary Tables 20 and 21). Weighted UniFrac
distance during this time was significantly less in case infants
than control infants, while unweighted UniFrac distance was not
(Fig. 4b, Extended Data Fig. 4c and Supplementary Tables 22 and
23). We did not observe a convergence of the bacterial microbiome
in case infants, possibly because case bacterial beta diversity was
already low 18–25 d before NEC.
Finally, we investigated the interactions between the virome
and bacterial microbiome using linear mixed modelling to identify
correlations between viral and bacterial abundance. We found that
the NEC-associated contigs were correlated with specific bacterial genera in case infants but did not follow the same correlation
pattern in control infants (Fig. 4c, left and Supplementary Table
24). For example, several NEC-associated contigs were positively
correlated with Escherichia and Streptococcus, while many of the
contigs associated with >10 d before NEC were negatively correlated with these genera. Correlations between NEC-associated
contigs and Proteus and Bifidobacterium were generally negative.
On the other hand, correlations with Acinetobacter, Clostridium,
Lactobacillus and Haemophilus were generally positive. These specific interactions were absent in control infants (Fig. 4c, right and
Supplementary Table 25). We also observed interactions between
658

control late-associated contigs and bacterial genera in control
samples (Extended Data Fig. 4d, left and Supplementary Table 26).
For example, specific contigs were positively correlated with
Enterococcaceae, Escherichia, Staphylococcus, Enterobacteriaceae,
Clostridium, Veillonella, Haemophilus, Streptococcus and
Enterococcus in control samples. We found relatively few associations between control time-associated contigs and bacterial genera
in case samples, except for some positive correlations with Dialister,
Bifidobacterium, Haemophilus and Streptococcus, and some negative
correlations with Corynebacterium, Proteus and Propionibacterium
(Extended Data Fig. 4d, right and Supplementary Table 27). Overall,
these results indicate that virus-bacteria interactions in case infants
who developed NEC differed substantially from control preterm
infants who did not develop NEC.

Discussion

We identified convergence of viral communities and specific viral
contigs in the days before NEC onset. The viral signatures of NEC
were observed immediately before NEC (beginning at 10 d preceding onset), compared to the bacterial shift observed 25 d before
NEC occurred. Detecting patterns of change in the virome before
NEC onset could enable early identification of preterm infants at
excessive risk of developing NEC.
We found substantial interindividual variation in preterm infant
gut viromes (Figs. 1 and 2). Viral family relative abundance, richness and alpha diversity varied between and within individuals
over time. We found that within-individual Bray–Curtis dissimilarity was significantly lower than between individuals, suggesting
that over time the viromes of individual infants were more similar
to self than non-self. This is consistent with previous studies that
found substantial interpersonal variation in the adult virome18,19.
The high proportion of Microviridae, Anelloviridae and Circoviridae
in some samples could reflect our use of Φ29 DNA polymerase
for viral DNA amplification, which biases towards small circular
single-strand DNA viruses23.
Interestingly, the gut viromes of preterm infants who developed
NEC converged before NEC ensued (Fig. 3). While viruses were
associated with specific times before NEC onset in both cases and
controls, the specific viruses in each group differed. This indicates
that accrual of NEC-associated viruses may be a distinctive feature
of the pre-NEC state. For example, virome convergence and shift
may alter mucosal immunity. Indeed, bacteriophages have been
implicated in mucosal immunity and pathobiology28–30. For example,
Escherichia coli, Lactobacillus plantarum and Bacteroides thetaiotaomicron bacteriophages stimulate interferon-γ production through
Toll-like receptor 9 signalling independent of bacteria and E. coli
bacteriophages worsen colitis in mice30. Staphylococcus aureus and
Pseudomonas aeruginosa bacteriophages stimulate both pro- and
anti-inflammatory gene expression and cytokine production31,32.
Given the ability of diverse bacteriophages to directly influence
mucosal immunity, it is possible that the viruses we identified trigger a cascade that stimulates inflammatory mucosal responses and
contributes to NEC pathogenesis. It is also possible that increases
in NEC-associated viruses may be a result of bacterial microbiome
alterations and mucosal inflammation occurring in the context of
bacterial community metabolism before NEC onset. Current data
do not permit us to speculate about the mechanistic underpinnings
of bacteriophage kinetics, bacterial interactions and the imminent
development of NEC. In addition to direct action of bacteriophages
on the host, several possibilities are worthy of consideration. These
include lysis-independent effects of bacteriophages on bacterial
metabolism and expression of effector molecules, lysis-dependent
release of host-injurious bacterial molecules and emergence in the
infant host of bacterial resistance to bacteriophages33.
We found that in the 25 d before NEC onset, the abundance of
Gammaproteobacteria, Bacilli, Enterococcaceae, Enterobacteriaceae
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and Veillonellaceae differed between case and control samples, as
reported previously6 (Fig. 4). Note that while that study focused on
the class Negativicutes, the preponderance of genera in that class
were Veillonella. However, only the Enterococcaceae family was
significantly different when adjusted for repeated sampling. These
results might be explained by differences in sample size (subset of
cohort), analyses pipelines (QIIME 2) and statistical methodologies
(ANCOM-II, adjusting for repeated sampling). Unlike virome beta
diversity, bacterial beta diversity did not converge. Rather, in the
25 d before NEC onset, weighted UniFrac distance between case
samples was low, that is, the bacterial community was highly similar among case infants. During the same time, interactions between
bacterial genera and viral contigs differed in the case and control
groups. Interestingly, several NEC-associated contigs were positively correlated with Escherichia and Streptococcus, while several
contigs associated with earlier periods were negatively correlated
with these genera. The differential correlation of NEC-associated
contigs and contigs associated with earlier periods with clinically
relevant6 bacterial genera may indicate a role for these viruses in
NEC development. Although bacteriophage predation on bacterial communities has been implicated in community modulation
in experimental systems in mice25, soil34 and bacteria isolated from
the fecal samples of young children35, whether the same mechanism
contributes to diseases such as NEC will need to be addressed in
future studies.
One limitation of this study was that the study population was
focused on a single hospital in the United States. It will be important to determine if geographical factors affect the virome in the
context of NEC since geography is one factor that can influence the
microbiome36 and virome37,38. It would also be informative to compare data from healthy full-term infants and preterm infants since
full-term infants were not studied in this project, although NEC
would not be a clinical outcome to which the virome can be related.
This sequential analysis of the gut virome of extremely preterm
infants from birth through to near-term (36 weeks’ PMA) provides
insight into community membership and dynamics over time and
in the weeks preceding NEC. The convergence of beta diversity
before NEC onset, driven by enrichment in specific viruses, supports a new line of investigation in the pathogenesis of NEC, a disease that despite intensive investigation is an important source of
morbidity and mortality in preterm infants.

Methods

Specimens. This study was approved by the Human Research Protection Office
of Washington University in St. Louis School of Medicine and Arizona State
University Institutional Review Board. Stools were collected prospectively from
preterm infants in the NICU at St. Louis Children’s Hospital as part of a larger
study on the preterm infant microbiome6,16,39,40 (Supplementary Table 1). Infants
were eligible if they weighed ≤1,500 g at birth and were expected to survive past the
first week of life6,16. Written informed consent, including consent to publish, was
obtained from the study participants’ families before enrolment. No compensation
was provided for the infant stool samples. All infant stools were collected and held
briefly at 4 °C, then stored at −80 °C before analysis.
For this study of the preterm virome, specimens were selected from infants
who were born at <27 weeks’ gestational age. Infants with NEC were selected
who had Bell stage II or higher NEC41. We excluded infants with major congenital
anomalies, including congenital heart disease, or spontaneous intestinal
perforation without radiographic evidence of NEC. One to two control infants
were selected for each case, matched by gestational age (±2 weeks) and weight
(±200 g) at birth, and availability of sufficient material to perform total nucleic
acid (TNA) extraction. Samples included in the analysis were collected during the
first three months of life. Samples were selected based on availability of sufficient
material for nucleic acid extraction, avoiding consecutive days of life when
possible. No statistical analyses were used to predetermine sample size.
We sequenced 138 samples from 23 preterm infants (9 infants with NEC
and 14 gestational age-matched controls; 11 males and 12 females) (Table 1,
Supplementary Table 2 and Extended Data Fig. 1) but only 135 were included in
the final analysis (2 samples were excluded because they contained insufficient
reads and 1 was excluded because it was obtained on a day of life that was
substantially older than the rest of the samples). For analyses of the virome and
660

microbiome preceding NEC, we counted time backwards from the day of NEC
onset for case infants (Extended Data Fig. 1b). For control infants, we counted
backwards from the day of life on which their matched case infant was diagnosed
with NEC. For the analysis of virome beta diversity preceding NEC (Fig. 3a),
paired case and control samples were used: for each case sample, one to two control
samples were selected depending on the number of control infants assigned to
that case infant. The closest pairings were chosen based on day of life at sample
collection (±3.5 d).
Virome sequencing. Stools were stored at −80 °C until TNA extraction. Stools
(approximately 200 mg) were chipped from frozen stock, diluted in PBS in a 1:6
ratio and filtered through a 0.45 μM membrane. TNA was extracted from stool
filtrates using the COBAS AmpliPrep Instrument (Roche Diagnostics). DNA was
amplified using Φ29 polymerase (GenomiPhi V2 Kit; GE Healthcare), libraries
constructed using the Nextera DNA library preparation kit and sequenced on the
Illumina MiSeq platform (v.2, 2 × 250 base pairs (bp)) as described elsewhere20,42.
PBS spiked with Orsay virus RNA generated by in vitro transcription was used as a
positive sequencing control. Samples were randomized for sample processing and
NGS using a random number generator. Sample processing and NGS were carried
out blind to the experimental groups. Subsequent analyses of sequencing data were
not performed blind because sample metadata such as infant ID, age and case/
control status were essential for statistical analysis.
Virome analysis. Sequencing reads were quality-filtered with BBTools (v.37.64)43,
phiX sequences removed, reads mapping to the human genome removed, paired
reads merged and reads deduplicated. Contigs were assembled from the reads
with phiX sequences removed using metaSPAdes (SPAdes v.3.14.0) (ref. 44).
A total of 778,612 contigs were assembled from the infant stool samples. Sample
and Orsay control contigs were deduplicated separately using CD-HIT-EST v.4.8.1
at minimum 95% identity and 95% overlap45. Overlapping contigs were merged
using minimus2 (as implemented in AMOS v.3.1.0, https://sourceforge.net/
projects/amos/files/amos/) (overlap minimum 95% identity)46. Sample and control
contigs were then combined into 1 file and filtered by length (minimum length
800 nucleotides). After deduplication and length filtering, 81,873 sample contigs
(median length = 1,379 bases; IQR = 998–2,369 bp) remained for analysis. The
length-filtered contigs were queried against the Gut Phage47 and the Gut Virome
databases48 using tblastx (minimum e-value 1 × 10−3), resulting in 55,002 candidate
viral contigs. The quality-filtered, deduplicated reads from the samples and Orsay
controls were mapped to the resulting contig database. Contig counts for each
sample were normalized by RPK as follows: (79,000/total quality control reads of
sample) × (number of reads mapping to each contig). The resulting read counts for
each contig were divided by the contig length in kilobases. After normalization,
counts smaller than 0.5 were removed to reduce noise. Circular contigs were
identified using VirSorter v.1.0.5 (ref. 49).
We used the decontam package v.1.4.0 in R v.3.6.1 (refs. 50,51) to
identify sequencing contaminants by comparing samples to Orsay controls
(threshold = 0.1). Contigs identified as contaminants were removed. Candidate
viral contigs were queried against the National Center for Biotechnology
Information (NCBI) NT database (downloaded February 2018) using megablast;
contigs with high percentage identity and query coverage to the human genome
were removed (percentage identity and query coverage both ≥90%; either
percentage identity or query coverage ≥95%). Two papillomavirus contigs that
were traced to contamination during the sequencing run were removed. After
decontamination, 40,210 viral contigs remained (median length = 1,562 bp;
IQR = 1,054–3,000 bp), of which 692 were circular.
Taxonomy for the viral contigs was assigned based on the taxonomy of the
viruses in the Gut Phage and Gut Virome databases. Contig ORFs were predicted
using Prodigal v.2.6.3 (ref. 52). Phage lifestyles were predicted using PHACTS v.0.3
(ref. 53). Lifestyle predictions were only performed for contigs with at least five
ORFs and which were not classified as eukaryotic viruses.
Ecological analysis. Alpha (Shannon index) and beta (Sorensen dissimilarity
and weighted Bray–Curtis dissimilarity) diversities were calculated with the
vegan package v.2.5-6 in R54, using RPK counts and contig presence–absence.
Hellinger distance was calculated with the adespatial package55 v.0.3-14 in R using
log-transformed RPK counts. PCoA was conducted with the phyloseq package
v.1.28.0 in R using weighted Bray–Curtis distance on RPK counts. Samples were
binned by week (postmenstrual age, PMA) for representation of virus family
relative abundance. Family relative abundance and Bray–Curtis dissimilarity
were plotted using Prism v.9.1.0 (GraphPad Software). Alpha diversity, richness
and PCoA plots were generated with ggplot2 v.3.3.3–3.3.5 in R. Locally estimated
scatterplot smoothing (LOESS) regression was used to obtain trend lines and 95%
confidence bands.
Matched case and control samples were used to compare between-case and
between-control Sorensen dissimilarity as a function of time preceding NEC onset
(sliding windows with a window size of 7 d, with 2 d steps between windows).
We used LEfSe to identify contigs associated with different times relative to NEC
onset56. A prevalence threshold of 10% was set for contigs being tested by LEfSe,
that is, contigs were only included in the LEfSe analysis if they were found in at
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least 10% of the samples being analysed. Prevalence and average abundance of
selected contigs were compared in cases and controls in 5 d intervals preceding
NEC onset, up to 25 d before NEC. All case and control samples in the 25 d before
NEC were included. Prevalence was calculated as the percentage of samples
within a time block with a hit to a particular contig. Abundance was calculated by
averaging all the case or control samples within a given block. Coefficients of linear
regression of individual contig prevalence and abundance over time (Fig. 3d and
Extended Data Fig. 3d) were obtained using the LINEST function in Microsoft
Excel v.16.45.
Bacterial microbiome analysis. Previously published 454 16S ribosomal RNA
gene sequencing data6 were downloaded from the NCBI Sequence Read Archive
(SRA) for all 40 case samples and the 41 control samples collected in the 25 d
preceding case NEC onset. Quality trimming was performed using bbduk
(BBTools v.37.64)43, followed by denoising using the dada2 plugin in QIIME 2
v.2019.1 (ref. 57). Samples were rarefied to a depth of 2,500 reads. Two samples were
dropped because of insufficient reads, resulting in 79 samples being used in the
final analysis. Alpha (Shannon index) and beta (weighted and unweighted UniFrac
distance) diversity were calculated in QIIME 2. Differentially abundant bacteria in
cases and controls were identified using the analysis of microbiome composition
(ANCOM-II58) in R. Correlations between contig and bacterial abundance were
determined by linear mixed modelling as implemented in MaAsLin 2 (ref. 59).
A prevalence threshold of 10% was set for contigs and bacterial genera being
analysed with MaAsLin 2, that is, contigs and bacterial genera had to be present
in at least 10% of the samples being analysed to be included. Correlations were
considered significant if they had a P < 0.05 and q < 0.25.
Statistical analyses. Metadata variables. Statistical significance for continuous and
categorical variables was assessed using the Mann–Whitney U-test or Fisher’s exact
test, respectively.
Virome analysis. Statistical significance of changes in alpha diversity and richness
over time were assessed by linear mixed modelling with postmenstrual age as a
fixed effect and infant ID as a random effect. Statistical significance for Bray–Curtis
dissimilarity (within-individual dissimilarity compared to between-individual
dissimilarity) was determined using the Mann–Whitney U-test. Statistical
significance for PCoA was determined using PERMANOVA, with PMA as a
continuous variable and case or control status as a categorical variable. To analyse
the time preceding NEC, differences in case or control Sorensen dissimilarity
across multiple time windows were assessed using a Kruskal–Wallis test with
Dunn’s multiple comparisons. Differences between case and control dissimilarity at
each specific window were assessed by the Mann–Whitney U-test. Differences in
prevalence and abundance of selected contigs in case samples across different time
points were compared using a Friedman test with Dunn’s multiple comparisons.
Bacterial analysis. Statistical significance of differences in case or control beta
diversity across multiple time windows was assessed using a Kruskal–Wallis test
with Dunn’s multiple comparisons. Differences between case and control beta
diversity at each window were compared using the Mann–Whitney U-test.
Mann–Whitney U-tests, Kruskal–Wallis tests with Dunn’s multiple
comparisons, Friedman tests with Dunn’s multiple comparisons, Fisher’s exact tests
and chi-squared tests were performed in Prism. PERMANOVA was performed
using the vegan package in R. Mixed linear modelling for virome alpha diversity
and richness was performed using the nlme package v.3.1-149 in R60. Where
appropriate, we chose non-parametric tests that do not assume data to be normally
distributed (for example, Mann–Whitney U-test, Kruskal–Wallis test). P ≤ 0.05 was
considered statistically significant. NS, P > 0.05, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001,
****P ≤ 0.0001.
Reporting Summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.

Data availability

The sequencing data have been deposited with the NCBI SRA (BioProject ID:
PRJNA682649). Reads mapping to the human genome were removed from the
submitted sequence data.

Code availability

The code used for the analyses in this study is available at https://github.com/
ASU-Lim-Lab/NEC-Virome.

Received: 7 January 2021; Accepted: 2 March 2022;
Published online: 21 April 2022

References

1. Knell, J., Han, S. M., Jaksic, T. & Modi, B. P. Current status of necrotizing
enterocolitis. Curr. Probl. Surg. 56, 11–38 (2019).

2. Battersby, C., Santhalingam, T., Costeloe, K. & Modi, N. Incidence of
neonatal necrotising enterocolitis in high-income countries: a systematic
review. Arch. Dis. Child Fetal Neonatal Ed. 103, F182–F189 (2018).
3. Rose, A. T. & Patel, R. M. A critical analysis of risk factors for necrotizing
enterocolitis. Semin. Fetal Neonatal Med. 23, 374–379 (2018).
4. Pammi, M. et al. Intestinal dysbiosis in preterm infants preceding necrotizing
enterocolitis: a systematic review and meta-analysis. Microbiome 5,
31 (2017).
5. Olm, M. R. et al. Necrotizing enterocolitis is preceded by increased gut
bacterial replication, Klebsiella, and fimbriae-encoding bacteria. Sci. Adv. 5,
eaax5727 (2019).
6. Warner, B. B. et al. Gut bacteria dysbiosis and necrotising enterocolitis in
very low birthweight infants: a prospective case-control study. Lancet 387,
1928–1936 (2016).
7. Neu, J. & Pammi, M. Necrotizing enterocolitis: the intestinal microbiome,
metabolome and inflammatory mediators. Semin. Fetal Neonatal Med. 23,
400–405 (2018).
8. Fundora, J. B., Guha, P., Shores, D. R., Pammi, M. & Maheshwari, A.
Intestinal dysbiosis and necrotizing enterocolitis: assessment for causality
using Bradford Hill criteria. Pediatr. Res. 87, 235–248 (2020).
9. Cheng, C., He, Y., Xiao, S., Ai, Q. & Yu, J. The association between enteric
viruses and necrotizing enterocolitis. Eur. J. Pediatr. 180, 225–232 (2021).
10. Turcios-Ruiz, R. M. et al. Outbreak of necrotizing enterocolitis caused by
norovirus in a neonatal intensive care unit. J. Pediatr. 153, 339–344 (2008).
11. Lodha, A., de Silva, N., Petric, M. & Moore, A. M. Human torovirus: a new
virus associated with neonatal necrotizing enterocolitis. Acta Paediatr. 94,
1085–1088 (2005).
12. Gessler, P., Bischoff, G. A., Wiegand, D., Essers, B. & Bossart, W.
Cytomegalovirus-associated necrotizing enterocolitis in a preterm twin after
breastfeeding. J. Perinatol. 24, 124–126 (2004).
13. Chany, C., Moscovici, O., Lebon, P. & Rousset, S. Association of coronavirus
infection with neonatal necrotizing enterocolitis. Pediatrics 69, 209–214 (1982).
14. Bäckhed, F. et al. Dynamics and stabilization of the human gut microbiome
during the first year of life. Cell Host Microbe 17, 690–703 (2015).
15. Milani, C. et al. The first microbial colonizers of the human gut: composition,
activities, and health implications of the infant gut microbiota. Microbiol.
Mol. Biol. Rev. 81, e00036-17 (2017).
16. La Rosa, P. S. et al. Patterned progression of bacterial populations in the
premature infant gut. Proc. Natl Acad. Sci. USA 111, 12522–12527 (2014).
17. Grier, A. et al. Impact of prematurity and nutrition on the developing gut
microbiome and preterm infant growth. Microbiome 5, 158 (2017).
18. Shkoporov, A. N. et al. The human gut virome is highly diverse, stable, and
individual specific. Cell Host Microbe 26, 527–541.e5 (2019).
19. Reyes, A. et al. Viruses in the faecal microbiota of monozygotic twins and
their mothers. Nature 466, 334–338 (2010).
20. Lim, E. S. et al. Early life dynamics of the human gut virome and bacterial
microbiome in infants. Nat. Med. 21, 1228–1234 (2015).
21. Reyes, A. et al. Gut DNA viromes of Malawian twins discordant for severe
acute malnutrition. Proc. Natl Acad. Sci. USA 112, 11941–11946 (2015).
22. Liang, G. et al. The stepwise assembly of the neonatal virome is modulated by
breastfeeding. Nature 581, 470–474 (2020).
23. Shkoporov, A. N. & Hill, C. Bacteriophages of the human gut: the “known
unknown” of the microbiome. Cell Host Microbe 25, 195–209 (2019).
24. Rasmussen, T. S. et al. Bacteriophage-mediated manipulation of the gut
microbiome—promises and presents limitations. FEMS Microbiol. Rev. 44,
507–521 (2020).
25. Hsu, B. B. et al. Dynamic modulation of the gut microbiota and
metabolome by bacteriophages in a mouse model. Cell Host Microbe 25,
803–814.e5 (2019).
26. Ott, S. J. et al. Efficacy of sterile fecal filtrate transfer for treating patients with
Clostridium difficile infection. Gastroenterology 152, 799–811.e7 (2017).
27. Zuo, T. et al. Bacteriophage transfer during faecal microbiota transplantation
in Clostridium difficile infection is associated with treatment outcome. Gut 67,
634–643 (2018).
28. Duerkop, B. A. et al. Murine colitis reveals a disease-associated bacteriophage
community. Nat. Microbiol. 3, 1023–1031 (2018).
29. Norman, J. M. et al. Disease-specific alterations in the enteric virome in
inflammatory bowel disease. Cell 160, 447–460 (2015).
30. Gogokhia, L. et al. Expansion of bacteriophages is linked to aggravated
intestinal inflammation and colitis. Cell Host Microbe 25, 285–299.e8 (2019).
31. Zhang, L. et al. Staphylococcus aureus bacteriophage suppresses LPS-induced
inflammation in MAC-T bovine mammary epithelial cells. Front. Microbiol. 9,
1614 (2018).
32. Van Belleghem, J. D., Clement, F., Merabishvili, M., Lavigne, R. &
Vaneechoutte, M. Pro- and anti-inflammatory responses of peripheral blood
mononuclear cells induced by Staphylococcus aureus and Pseudomonas
aeruginosa phages. Sci. Rep. 7, 8004 (2017).
33. Oechslin, F. Resistance development to bacteriophages occurring during
bacteriophage therapy. Viruses 10, 351 (2018).

Nature Microbiology | VOL 7 | May 2022 | 653–662 | www.nature.com/naturemicrobiology

661

Articles

Nature Microbiology

34. Braga, L. P. P. et al. Impact of phages on soil bacterial communities and nitrogen
availability under different assembly scenarios. Microbiome 8, 52 (2020).
35. Khan Mirzaei, M. et al. Bacteriophages isolated from stunted children can
regulate gut bacterial communities in an age-specific manner. Cell Host
Microbe 27, 199–212.e5 (2020).
36. Yatsunenko, T. et al. Human gut microbiome viewed across age and
geography. Nature 486, 222–227 (2012).
37. Zuo, T. et al. Human-Gut-DNA virome variations across geography, ethnicity,
and urbanization. Cell Host Microbe 28, 741–751.e4 (2020).
38. Holtz, L. R. Putting the virome on the map: the influence of host geography
and ethnicity on the gut virome. Cell Host Microbe 28, 636–637 (2020).
39. Gasparrini, A. J. et al. Antibiotic perturbation of the preterm infant gut
microbiome and resistome. Gut Microbes 7, 443–449 (2016).
40. Gibson, M. K. et al. Developmental dynamics of the preterm infant gut
microbiota and antibiotic resistome. Nat. Microbiol. 1, 16024 (2016).
41. Walsh, M. C. & Kliegman, R. M. Necrotizing enterocolitis: treatment based
on staging criteria. Pediatr. Clin. North Am. 33, 179–201 (1986).
42. Maqsood, R. et al. Discordant transmission of bacteria and viruses from
mothers to babies at birth. Microbiome 7, 156 (2019).
43. Bushnell, B. BBMap. Version 37.64, https://sourceforge.net/projects/bbmap/
(2017).
44. Nurk, S., Meleshko, D., Korobeynikov, A. & Pevzner, P. A. metaSPAdes: a new
versatile metagenomic assembler. Genome Res. 27, 824–834 (2017).
45. Li, W. & Godzik, A. Cd-hit: a fast program for clustering and comparing
large sets of protein or nucleotide sequences. Bioinformatics 22,
1658–1659 (2006).
46. Sommer, D. D., Delcher, A. L., Salzberg, S. L. & Pop, M. Minimus: a fast,
lightweight genome assembler. BMC Bioinformatics 8, 64 (2007).
47. Camarillo-Guerrero, L. F., Almeida, A., Rangel-Pineros, G., Finn, R. D. &
Lawley, T. D. Massive expansion of human gut bacteriophage diversity. Cell
184, 1098–1109.e9 (2021).
48. Gregory, A. C. et al. The gut virome database reveals age-dependent
patterns of virome diversity in the human gut. Cell Host Microbe 28,
724–740.e8 (2020).
49. Roux, S., Enault, F., Hurwitz, B. L. & Sullivan, M. B. VirSorter: mining viral
signal from microbial genomic data. PeerJ 3, e985 (2015).
50. Davis, N. M., Proctor, D. M., Holmes, S. P., Relman, D. A. & Callahan, B. J.
Simple statistical identification and removal of contaminant sequences in
marker-gene and metagenomics data. Microbiome 6, 226 (2018).
51. R Core Team. R: a Language and Environment for Statistical Computing
(R Foundation for Statistical Computing, 2019).
52. Hyatt, D. et al. Prodigal: prokaryotic gene recognition and translation
initiation site identification. BMC Bioinformatics 11, 119 (2010).
53. McNair, K., Bailey, B. A. & Edwards, R. A. PHACTS, a computational approach
to classifying the lifestyle of phages. Bioinformatics 28, 614–618 (2012).
54. Oksanen, J. et al. vegan: Community ecology package. R package version
2.5-6 https://cran.r-project.org/web/packages/vegan/index.html (2019).
55. Dray, S. et al. adespatial: Multivariate multiscale spatial analysis. R package
version v.0.3-14 https://cran.r-project.org/web/packages/adespatial/index.html
(2021).
56. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome
Biol. 12, R60 (2011).
57. Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome
data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019).

662

58. Lin, F. H. HuangLin/ANCOM: Third release of ANCOM v.2.1. Zenodo
https://zenodo.org/record/3577802#.Yi78VRPP3Aw (2019).
59. Mallick, H. et al. Multivariable association discovery in population-scale
meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).
60. Pinheiro, J. et al. nlme: Linear and nonlinear mixed effects models. R package
version v.3.1-149 https://cran.r-project.org/web/packages/nlme/nlme.pdf
(2020).

Acknowledgements

We thank the study participants and their families. This research was funded by
National Institutes of Health grant nos. R01HD092311 (E.S.L.), R00DK107923
(E.S.L.)., R01DK122029 (L.R.H.), R01HD092414 (P.I.T.), UH3AI083265 (P.I.T.) and
P30DK052574 (Biobank Core), as well as funding from the Children’s Discovery
Institute of Washington University.

Author contributions

P.I.T., L.R.H., E.S.L., B.B.W. conceptualized the study. E.A.K. curated the data.
E.A.K. carried out the formal analysis. P.I.T., B.B.W., J.A.H., L.A.L. and I.M.N. recruited
the study participants and managed the metadata. E.A.K., C.R. and C.H-M. carried out
the investigation. B.B.W. and P.I.T. managed the resources. E.S.L. and L.R.H. supervised
the study. E.A.K. and E.S.L. wrote the original draft. All authors contributed to, reviewed
and approved the final manuscript.

Competing interests

The authors declare no competing interests.

Additional information

Extended data is available for this paper at https://doi.org/10.1038/s41564-022-01096-x.
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41564-022-01096-x.
Correspondence and requests for materials should be addressed to Lori R. Holtz or
Efrem S. Lim.
Peer review information Nature Microbiology thanks Corinne Maurice and the other,
anonymous, reviewer(s) for their contribution to the peer review of this work.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The images or other
third party material in this article are included in the article’s Creative Commons license,
unless indicated otherwise in a credit line to the material. If material is not included in
the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2022

Nature Microbiology | VOL 7 | May 2022 | 653–662 | www.nature.com/naturemicrobiology

Nature Microbiology

Articles

Extended Data Fig. 1 | Sample timeline. a: All samples by postmenstrual age at sample collection. b: Samples used for analysis of time relative to NEC
onset (Figs. 3 and 4). Matched case and control infants are grouped together. Paired samples used for beta diversity analysis are indicated in red and blue
(Figs. 3a and 4b).
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Extended Data Fig. 2 | Relative abundance by week of life, Sorensen dissimilarity and Hellinger distance within and between infants. a: Virus family
relative abundance in control samples from Fig. 1a, grouped by week of life rather than postmenstrual age. Multiple pie charts in the same square indicate
multiple samples for an infant in the same week. b. Sorensen dissimilarity and Hellinger distance within and between control infants, n = 14 infants. Center
line = median; box limits = 25th and 75th percentiles; whiskers = 2.5 and 97.5 percentiles. Statistical significance assessed by two-sided Mann-Whitney
test, p < 0.0001. c: Virus family relative abundance in case samples from Fig. 2a, grouped by week of life rather than PMA. Multiple pie charts in the same
square indicate multiple samples for an infant in the same week. The same colors are used to indicate virus families in A and C. d: Sorensen dissimilarity
and Hellinger distance within and between case infants, n = 9 infants. Center line = median; box limits = 25th and 75th percentiles; whiskers = 2.5 and
97.5 percentiles. Statistical significance assessed by two-sided Mann-Whitney test, p = 0.04 and p = 0.002, respectively.
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Extended Data Fig. 3 | Control infant discriminant contigs and phage lifestyle predictions. a: Prevalence and abundance of NEC-associated contigs in
control infants, in 5-day intervals prior to respective case NEC onset. Statistical significance assessed by Friedman test with Dunn’s multiple comparisons
(p-values in Supplementary Table 14). b: Linear discriminant analysis effect size (LEfSe) of contigs in control samples. Purple indicates features associated
with 0–10 days prior to case NEC onset. Green indicates features associated with 10–46 days prior to case NEC onset. c: Prevalence and abundance of
control early- and late-associated contigs in control infants (left) and case infants (right), in 5-day intervals prior to case NEC onset. Statistical significance
assessed by Friedman test with Dunn’s multiple comparisons (p-values in Supplementary Tables 17,18). d: For each control discriminant contig, linear
regression was performed on prevalence and average abundance values in 5-day intervals prior to NEC in cases (red) and controls (blue). Regression
coefficients for abundance and prevalence were plotted on the x- and y-axes, respectively. E: Lifestyle predictions (temperate or lytic) for case and control
late-associated viral contigs.
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Extended Data Fig. 4 | ANCOM-II, unweighted bacterial beta diversity, and bacterial-viral interactions in controls. a: ANCOM-II comparing bacterial
family abundance in case and control samples, unadjusted (left) and adjusted (right) for repeated sampling. W statistic is the number of significant
comparisons between a taxon and the other taxa being tested. CLR mean difference corresponds to effect size. Points in red represent taxa that are
differentially abundant when W statistic threshold is set at the 70th percentile. Points in orange represent taxa that are differentially abundant when W
statistic threshold is set at the 60th percentile. Points in blue represent taxa that are not differentially abundant. b. ANCOM-II comparing bacterial
class abundance in case and control samples, unadjusted (left) and adjusted (right) for repeated sampling. W statistic is the number of significant
comparisons between a taxon and the other taxa being tested. CLR mean difference corresponds to effect size. Points in red represent taxa that
are differentially abundant when W statistic threshold is set at the 70th percentile. Points in blue represent taxa that are not differentially abundant.
c: Unweighted UniFrac distance between case samples (red) and between matched control samples (blue) in sliding windows prior to NEC onset
(7-day windows with 2-day steps). Medians with 95% confidence intervals are shown. Statistical significance at each window assessed by two-sided
Mann-Whitney U test. d: Significant correlations between control discriminant contigs (late- and early-associated) and bacterial genera in control infants
(left) and case infants (right). Dendrograms were ordered based on row and column means.
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